Poor
Needs Revision
Patient Risk:
Info
Summary
Most alcohol–pregabalin interaction claims are not supported by the provided FDA label sections. The only label-supported elements among the claims relate to pregabalin causing dizziness/somnolence and potential impairment with driving/operating machinery (5.5).
Category Scores
Accurate Statements
Lyrica (pregabalin) works in the brain and nervous system to reduce symptoms such as nerve pain and certain seizure-related symptoms.
Supported in part by 12.1 Mechanism of Action (central nervous system binding/anti-nociceptive and antiseizure effects).
People should avoid driving or operating machinery when using Lyrica.
5.5 Dizziness and Somnolence: dizziness/somnolence may impair ability to perform tasks such as driving or operating machinery.
Focus on safety measures such as avoiding driving.
5.5 Dizziness and Somnolence (tasks such as driving/operating machinery may be impaired).
Unsupported Statements
Alcohol can worsen the side effects of Lyrica (pregabalin) more than it affects Lyrica’s direct therapeutic effect.
Not supported by the provided label sections (no alcohol-specific comparison or statement).
Alcohol adds central nervous system (CNS) depressant effects.
Not supported by the provided label sections.
Combining alcohol and pregabalin makes sedation more likely.
Not supported by the provided label sections (no alcohol–pregabalin sedation statement).
Combining alcohol and pregabalin makes dizziness more likely.
Not supported by the provided label sections.
Combining alcohol and pregabalin makes impaired coordination more likely.
Not supported by the provided label sections.
The combination of alcohol and pregabalin can make it harder to tolerate the medication and stay on the dosing plan.
Not supported by the provided label sections.
The combination of alcohol and pregabalin increases the risk of excessive sedation or dizziness.
Not supported by the provided label sections.
The combination of alcohol and pregabalin may reduce the ability to function normally while taking the drug.
Not supported by the provided label sections (no alcohol-specific functional impact).
Drinking alcohol while on Lyrica can cause more pronounced drowsiness.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can cause more pronounced dizziness.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can worsen balance and coordination.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can increase fall or injury risk.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can slow reaction time.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can impair judgment.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can increase the risk of feeling faint.
Not supported by the provided label sections.
Drinking alcohol while on Lyrica can increase the risk of feeling overly sedated.
Not supported by the provided label sections.
The effects of alcohol and pregabalin together are driven by additive CNS depression.
Not supported by the provided label sections.
The provided information does not specify a change in Lyrica’s blood concentration from alcohol.
The provided label excerpts do not address alcohol effects on pregabalin concentrations; therefore the claim is not supported by the provided label sections.
The main interaction emphasized is increased CNS depression (sedation and impairment) from using alcohol while taking pregabalin, rather than a predictable reduction in the drug’s efficacy.
Not supported by the provided label sections.
Typical guidance is to avoid alcohol (or use caution and limit it strongly) during treatment with Lyrica.
Not supported by the provided label sections.
Avoidance/caution with alcohol is especially important when starting Lyrica.
Not supported by the provided label sections.
Avoidance/caution with alcohol is especially important after dose increases of Lyrica.
Not supported by the provided label sections.
Avoidance/caution with alcohol is especially important if a person is already prone to dizziness or sleepiness.
Not supported by the provided label sections.
The key risk from combining alcohol and Lyrica is excessive sedation and impaired coordination.
Not supported by the provided label sections.
In more severe situations, the combination can lead to dangerous levels of impairment.
Not supported by the provided label sections.
Alcohol increases the risk of impaired coordination while using Lyrica.
Not supported by the provided label sections.
The risk increases if other substances that depress the CNS (e.g., sedatives or certain sleep medicines) are also taken with alcohol and Lyrica.
Not supported by the provided label sections.
The effects of alcohol and pregabalin can stack with other CNS depressants.
Not supported by the provided label sections.
Liver disease or heavy alcohol use can increase the likelihood of problematic sedation and falls.
Not supported by the provided label sections.
A highlighted interaction concern is primarily additive CNS depression.
Not supported by the provided label sections.
Do not take extra doses to balance alcohol after taking Lyrica.
Not supported by the provided label sections.
People should watch for excessive drowsiness or unsteadiness after drinking alcohol and taking Lyrica.
Not supported by the provided label sections.
People should seek medical advice promptly if they feel unusually sedated, confused, or have trouble staying awake after drinking alcohol and taking Lyrica.
Not supported by the provided label sections.
Contradictions
Important Omissions
The claim set does not assess or cite label-required safety topics such as boxed warnings, contraindications, dosing/administration precautions, or monitoring/management instructions relevant to safety. (These sections are not provided in the label excerpts, so label-coverage cannot be verified.)
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Info
While pregabalin-related dizziness/somnolence and task impairment are supported (5.5), the majority of alcohol-specific incremental risk statements are not supported by the provided label excerpts, reducing label fidelity. No direct contradiction to the provided sections was identified.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Needs Revision
Primary Issue
Most alcohol–pregabalin interaction claims (sedation/dizziness/coordination/falls/impairment and alcohol avoidance timing) are absent from the provided FDA label sections.
Suggested Improvement
Restrict statements to label-supported content from 5.5 (pregabalin dizziness/somnolence and impairment with driving/operating machinery) and 12.1 (mechanism of action). Remove or re-phrase alcohol-specific interaction and severity claims unless supported by the provided label text.